1. Home
  2. AGEN vs SFBC Comparison

AGEN vs SFBC Comparison

Compare AGEN & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.05

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Logo Sound Financial Bancorp Inc.

SFBC

Sound Financial Bancorp Inc.

N/A

Current Price

$43.89

Market Cap

103.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AGEN
SFBC
Founded
1994
1953
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
103.7M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
SFBC
Price
$3.05
$43.89
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$14.50
N/A
AVG Volume (30 Days)
613.6K
5.0K
Earning Date
03-10-2026
01-27-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
55.90
EPS
N/A
2.81
Revenue
$106,829,000.00
$38,764,000.00
Revenue This Year
$5.19
N/A
Revenue Next Year
$68.25
N/A
P/E Ratio
N/A
$15.79
Revenue Growth
N/A
8.35
52 Week Low
$1.38
$42.75
52 Week High
$7.34
$52.13

Technical Indicators

Market Signals
Indicator
AGEN
SFBC
Relative Strength Index (RSI) 45.17 47.33
Support Level $2.76 $43.71
Resistance Level $3.15 $44.37
Average True Range (ATR) 0.18 0.34
MACD 0.02 -0.01
Stochastic Oscillator 61.00 18.24

Price Performance

Historical Comparison
AGEN
SFBC

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

Share on Social Networks: